0001127602-21-013551.txt : 20210409
0001127602-21-013551.hdr.sgml : 20210409
20210409160432
ACCESSION NUMBER: 0001127602-21-013551
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210330
FILED AS OF DATE: 20210409
DATE AS OF CHANGE: 20210409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeLong Mark Jeffrey
CENTRAL INDEX KEY: 0001856078
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 21817837
MAIL ADDRESS:
STREET 1: 100 5TH AVENUE, 3RD FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
3
1
form3.xml
PRIMARY DOCUMENT
X0206
3
2021-03-30
0
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001856078
DeLong Mark Jeffrey
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Senior Vice President
Common Stock
8698
D
Stock Option (Right to Buy)
44.90
2031-01-27
Common Stock
30000
D
Stock Option (Right to Buy)
44.33
2030-02-09
Common Stock
18750
D
Stock Option (Right to Buy)
15.52
2028-02-04
Common Stock
50000
D
Stock Option (Right to Buy)
13.85
2029-02-27
Common Stock
30000
D
This stock option will vest as to 25% of the shares underlying the options on the first anniversary of the grant date, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.
/s/ David Watson, attorney-in-fact for Mark Delong
2021-04-09
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): POA
Know all by these presents, that the undersigned hereby makes,
constitutes and appoints each of David O. Watson and Timothy Sullivan,
signing singly and each acting individually, as the undersigneds true and
lawful attorneyinfact with full power and authority as hereinafter
described to
1 execute for and on behalf of the undersigned, in the undersigneds
capacity as officer of Apellis Pharmaceuticals, Inc. the Company,
Forms?3, 4, and 5 including any amendments thereto in accordance
with Section?16a of the Securities Exchange Act of 1934, as amended,
and the rules thereunder the Exchange Act
2 do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to prepare, complete and
execute any such Form?3, 4, or 5, prepare, complete and execute any
amendment or amendments thereto, and timely deliver and file such form
with the United States Securities and Exchange Commission the SEC and
any stock exchange or similar authority, including without limitation the
filing of a Form ID, Update Passphrase, or any other application materials
to enable the undersigned to gain or maintain access to the Electronic Data
Gathering, Analysis and Retrieval system of the SEC
3 seek or obtain, as the undersigneds representative and on the
undersigneds behalf, information regarding transactions in the Companys
securities from any third party, including brokers, employee benefit plan
administrators and trustees, and the undersigned hereby authorizes any
such person to release any such information to such attorneyinfact and
approves and ratifies any such release of information and
4 take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorneyinfact, may be of
benefit to, in the best interest of, or legally required by, the undersigned,
it being understood that the documents executed by such attorneyinfact on
behalf of the undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such attorneyinfact may
approve in suchattorneyinfact discretion.
The undersigned hereby grants to each such attorneyinfact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that
such attorneyinfact, or such attorneyinfact substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of attorney
and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneyinfact, in serving in such capacity at the
request of the undersigned, are not assuming nor relieving, nor is the
Company assuming nor relieving, any of the undersigneds responsibilities
to comply with Section?16 of the Exchange Act. The undersigned
acknowledges that neither the Company nor the foregoing attorneyinfact
assume i any liability for the undersigneds responsibility to comply
with the requirements of the Exchange Act, ii any liability of the
undersigned for any failure to comply with such requirements, or iii
any obligation or liability of the undersigned for profit disgorgement
under Section 16b of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms?3, 4, and 5 with respect
to the undersigneds holdings of and transactions in securities issued
by the Company, unless earlier revoked by the undersigned in a signed
writing delivered to the foregoing attorneyinfact.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 31st day of March, 2021. Mark DeLong
Name Mark DeLong
LIMITED POWER OF ATTORNEY
FOR SECTION 16 REPORTING OBLIGATIONS
DC 573852 1301253 v1
ActiveUS 186209981v 1